Hawon Pharm. Co. appointed as good potential company.

Published: 2002-10-07 06:57:00

Updated: 2002-10-07 06:57:00

Hawon pharmaceutical company has been assessed by the KIST with high standardized enterprise in terms of their product and R&D capability and recently received a letter of merit from the KIST.

For the purpose of supporting a small and medium industry with good potential advanced technology, th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK